Your session is about to expire
← Back to Search
Lifestyle Modification for Diabetic Neuropathy (IMABIN Trial)
IMABIN Trial Summary
This trial will test an aerobic exercise and balance intervention in participants with impaired glucose regulation (IGR). The investigators will examine if this intervention can improve autonomic function and balance control when compared to patients who receive standard care.
IMABIN Trial Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowIMABIN Trial Timeline
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.IMABIN Trial Design
Find a Location
Who is running the clinical trial?
Media Library
- I have nerve pain or weakness not caused by diabetes.I have had issues with my blood sugar levels recently.My nerve pain is likely due to blood sugar issues.I am at risk for diabetes or have diabetes based on my HBA1C levels or glucose tests.My diabetes medication has been stable for at least 3 months.I do not have any severe illnesses that would stop me from completing the study.Your HbA1c level should be less than 9%.My severe nerve damage affects my body's automatic functions and may limit my study participation.I am between 30 and 80 years old.I agree to switch from coumadin for a skin biopsy.You have a specific type of nerve damage related to diabetes, as defined by a group of experts.I agree to switch from coumadin for a skin biopsy.
- Group 1: Diet, Physical Activity and Balance Enhancement Program (DPAE
- Group 2: Standard Care (SC)
- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
Can I contribute to this research initiative?
"To take part in this trial, potential participants must have impaired glucose tolerance and be between the ages of 30 and 80. This medical study is accepting 60 applicants in total."
Is enrollment for this experiment still open?
"According to clinicaltrials.gov, this experiment is no longer enrolling patients; the study was initially posted on November 14th 2013 and last edited March 21st 2022. However, there are 498 other medical studies currently recruiting volunteers for participation."
Who else is applying?
What state do they live in?
What site did they apply to?
What portion of applicants met pre-screening criteria?
How many prior treatments have patients received?
Share this study with friends
Copy Link
Messenger